Sunday, October 25, 2020
Home Life Style Health & Fitness Government Experts Back Experimental Treatment for Children with Peanut Allergies

Government Experts Back Experimental Treatment for Children with Peanut Allergies

The outside panel of advisers to the Food and Drug Administration voted overwhelmingly in favor of the treatment from Aimmune Therapeutics

Government experts Friday backed an experimental treatment for children with peanut allergies that could become the first federally approved option for preventing life-threatening reactions.

The treatment is daily capsules of peanut powder that gradually help children build up a tolerance.

The outside panel of advisers to the Food and Drug Administration voted overwhelmingly in favor of the treatment from Aimmune Therapeutics. The nonbinding vote amounts to an endorsement for approval.

The FDA is expected to make its final decision by January.

Government, Experts, Experimental
Government experts Friday backed an experimental treatment for children with peanut allergies that could become the first federally approved option. Pixabay

Important option

The panelists said the medication was an important option for parents and children dealing with peanut allergies. However, several also said they had concerns because the pill has to be taken continuously to maintain its effect.

An estimated 1.6 million children and teenagers in the U.S. would be eligible for the medication, to be sold as Palforzia, which is intended for ages 4 to 17.

Peanut allergy is the most common food allergy in the country and the standard treatment involves strictly monitoring what children eat. That approach doesn’t always work and accidental exposure is common, sending 1 in 4 children with peanut allergies to the emergency room every year.

Also Read- Google Changes Its Global Algorithm To Highlight Original Reporting

‘Peace of mind … invaluable’

Parents at Friday’s meeting urged approval of the drug, describing the anxiety of watching their children’s diet and daily routine, even avoiding public places and transportation because of possible peanut residues.

“These are constant and real fears with extreme consequences,” said Cathy Heald of Dallas, whose 12-year-old son Charlie took part in a study of the treatment.

Heald said her son’s improved tolerance allowed him to travel overseas by himself for the first time.

Government, Experts, Experimental

The treatment is daily capsules of peanut powder that gradually help children build up a tolerance. Pixabay

“The peace of mind this treatment brings is invaluable,” said Hill, whose trip to the meeting was paid by Aimmune.

Risks of treatment

After one year, about 66% of study participants who took the pills could tolerate the equivalent of three to four peanuts, compared to just 4% of patients who received a dummy treatment. At the beginning of the study, most participants could not tolerate even a minuscule amount of peanuts.

But the benefits of the treatment came with risks. More than 9% of patients taking the pills reported severe allergic reactions, more than twice the number in the placebo group. And 11% of patients dropped out of the company’s study because of side effects.

Also Read- Google Play Store To Finally Get a Dark Theme

“The effectiveness of the treatment has, in fact, not been demonstrated,” said Dr. John Kelso, of Scripps Clinic in San Diego, who voted against the treatment.

The California-based company has previously said it expects the first six months of treatment to cost $5,000 to $10,000 and $300 to $400 a month after that. The company declined to elaborate on price earlier this week.

Aimmune is pursuing other treatments for common food allergies, including eggs. The company does not yet have any products on the market. (VOA)

STAY CONNECTED

19,120FansLike
362FollowersFollow
1,778FollowersFollow

Most Popular

Stars and Planets Grow Up Together, says Study

In a unique study, astronomers have found compelling evidence that the planets begin forming while stars are still infants and they grow up together...

Diana Penty Talks About Digitalizing Fashion Shows

In a day and age where most things are digital and everything has moved online, one would imagine the same to be the case...

New AI Predicts Risks of Developing Acute Kidney Injury

A new artificial-intelligence-based tool can help clinicians predict which hospitalized patients face a high risk of developing acute kidney injury (AKI), say, researchers, including...

Artificial Limbs to Differently-Abled by Charitable Body

Narayan Seva Sansthan, which runs charitable hospitals in the country for the differently-abled, particularly polio-affected and those affected by birth, has launched a campaign...

Need for Continuing the Polio Immunization During Pandemic

As World Polio Day is observed around the globe amid the COVID-19 pandemic on Saturday, experts underlined the need for continuing the polio immunization...

Patients with NCD More Vulnerable to COVID in India

Researchers have revealed that the COVID-19 pandemic came as a double blow for people with non-communicable diseases (NCDs) such as diabetes, cancer, respiratory problems,...

How to Check if Something is an Online Scam

While there’s no failsafe way to recognize a scam, it never hurts to be vigilant. You can protect yourself when you know what to...

Washing Hands Thoroughly is Far off the Basics

Medical authorities have made themselves clear: washing our hands thoroughly and frequently with soap, or using a hand sanitizer in absence of soap and...

Recent Comments